Pages that link to "Q40981381"

The following pages link to Meloxicam inhibits the growth of colorectal cancer cells (Q40981381):

Displaying 49 items.

• Use of NSAIDs for the Chemoprevention of Colorectal Cancer (Q28165741) (← links)
• Non steroidal anti-inflammatory drugs and COX-2 inhibitors as anti-cancer therapeutics: hypes, hopes and reality (Q28166312) (← links)
• Regulation of cell growth by selective COX-2 inhibitors in oral carcinoma cell lines (Q28166480) (← links)
• Role of cyclooxygenase-2 in the angiogenesis of colorectal cancer (Q28196352) (← links)
• Role of cyclooxygenase-2 in the carcinogenesis of gastrointestinal tract cancers: a review and report of personal experience (Q28303196) (← links)
• A cyclooxygenase-2 inhibitor (SC-58125) blocks growth of established human colon cancer xenografts (Q28363033) (← links)
• The role of cyclooxygenases in inflammation, cancer, and development (Q33814331) (← links)
• Analysis of co-spray-dried meloxicam–mannitol systems containing crystalline microcomposites (Q33926226) (← links)
• Targeting the eicosanoid pathway in non-small-cell lung cancer (Q33936807) (← links)
• Eicosanoids and the large intestine (Q33950294) (← links)
• Identification of a novel class of anti-inflammatory compounds with anti-tumor activity in colorectal and lung cancers (Q34024178) (← links)
• Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia (Q34082384) (← links)
• Photophysical studies of oxicam group of NSAIDs: piroxicam, meloxicam and tenoxicam (Q34186309) (← links)
• JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1. (Q34218711) (← links)
• Is inhibition of cyclooxygenase required for the anti-tumorigenic effects of nonsteroidal, anti-inflammatory drugs (NSAIDs)? In vitro versus in vivo results and the relevance for the prevention and treatment of cancer (Q34537518) (← links)
• Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. (Q34568144) (← links)
• Molecular biomarkers of colorectal carcinogenesis and their role in surveillance and early intervention. (Q35123465) (← links)
• Chemoprevention of gastrointestinal malignancies (Q35212282) (← links)
• 11β-Hydroxysteroid Dehydrogenase Type II is a Potential Target for Prevention of Colorectal Tumorigenesis (Q37078077) (← links)
• Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer (Q37290958) (← links)
• Lung inflammatory response syndrome after cardiac-operations and treatment of lornoxicam (Q37663916) (← links)
• Stimulatory Action of Cyclooxygenase Inhibitors on Hematopoiesis: A Review (Q38009199) (← links)
• Strategies for meloxicam delivery to and across the skin: a review (Q38766193) (← links)
• Formulation and development of di-dependent microparticulate system for colon-specific drug delivery (Q38990611) (← links)
• Synergistic effect of gefitinib and rofecoxib in mesothelioma cells (Q39292338) (← links)
• Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells. (Q39393965) (← links)
• Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers (Q40117008) (← links)
• Radiosensitizing potential of the selective cyclooygenase-2 (COX-2) inhibitor meloxicam on human glioma cells. (Q40143351) (← links)
• Specific COX-2 inhibitor, meloxicam, suppresses proliferation and induces apoptosis in human HepG2 hepatocellular carcinoma cells (Q40214237) (← links)
• Effects of transforming growth factor-beta in the development of inflammatory pseudotumour-like lesions in a murine model (Q40278316) (← links)
• Selective inhibition of cyclooxygenase-2 inhibits colon cancer cell adhesion to extracellular matrix by decreased expression of beta1 integrin. (Q40455953) (← links)
• Piroxicam selectively inhibits the growth of premalignant and malignant human oral cell lines by limiting their progression through the S phase and reducing the levels of cyclins and AP‐1 (Q40624967) (← links)
• Characterization of a rat model of metastatic prostate cancer bone pain (Q41244868) (← links)
• Sulindac sulfide, but not sulindac sulfone, inhibits colorectal cancer growth. (Q41851785) (← links)
• COX-1 and COX-2 products in the gut: therapeutic impact of COX-2 inhibitors (Q43086302) (← links)
• Non-steroidal anti-inflammatory drugs inhibit telomerase activity in head and neck squamous carcinoma cell lines (Q43844202) (← links)
• Selective cyclooxygenase-2 inhibitors show a differential ability to inhibit proliferation and induce apoptosis of colon adenocarcinoma cells (Q44205593) (← links)
• Incorporation of NSAIDs in micelles: implication of structural switchover in drug-membrane interaction (Q44497210) (← links)
• Anti-tumor effect of non-steroidal anti-inflammatory drugs on human ovarian cancers (Q46833782) (← links)
• Design and characteristics of gellan gum beads for modified release of meloxicam. (Q48262549) (← links)
• Juvenile ovary to testis transition in zebrafish involves inhibition of ptges (Q48600571) (← links)
• Meloxicam-loaded nanocapsules as an alternative to improve memory decline in an Alzheimer's disease model in mice: involvement of Na( ), K( )-ATPase (Q48874402) (← links)
• Particle engineering/different film approaches for earlier absorption of meloxicam (Q51137697) (← links)
• The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action. (Q52864305) (← links)
• Inflammation and oxidative stress in testicular torsion: do they deserve intensive treatment to save both guilty and innocent testes? (Q53260333) (← links)
• Spectroscopic, biological, and molecular modeling studies on the interactions of [Fe(III)-meloxicam] with G-quadruplex DNA and investigation of its release from bovine serum albumin (BSA) nanoparticles. (Q54178230) (← links)
• Preferential inhibition of cyclooxygenase-2 by meloxicam in human rheumatoid synoviocytes (Q73794766) (← links)
• Effect of the specific cyclooxygenase-2 inhibitor meloxicam on tumour growth and cachexia in a murine model (Q73911328) (← links)
• Formulation and development of release modulated colon targeted system of meloxicam for potential application in the prophylaxis of colorectal cancer (Q82784637) (← links)